MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Predictors of Orthostatic Hypotension in Patients with Parkinson’s Disease

    C-C. Lin, J. Heisler, H. Patel, W. Ondo (Houston, TX, USA)

    Objective: To investigate factors that may affect blood pressure in patients with PD (Parkinson’s disease). Background: PD affects the autonomic nervous system, potentially leading to…
  • 2019 International Congress

    Grey matter atrophy in Parkinson’s disease with long-duration response

    G. Donzuso, G. Sciacca, G. Mostile, A. Nicoletti, M. Zappia (Catania, Italy)

    Objective: Aim of the study is to investigate neuroanatomical correlates of Long-Duration Response using structural magnetic resonance imaging (MRI) and voxel-based morphometry analysis. Background: Parkinson…
  • 2019 International Congress

    Visual assessment of dopamine transporter imaging in normal pressure hydrocephalus

    KY. Kwon, H. Ju, K. Im, JY. Lee, MY. Ahn (Seoul, Republic of Korea)

    Objective: We aimed to investigate detailed analysis for striatal dopaminergic depletion in idiopathic normal pressure hydrocephalus (iNPH) with visual assessment. Background: Variable degree of parkinsonism…
  • 2019 International Congress

    Neuronal Network Underlying Speech Difficulties in Parkinson’s Disease

    S. Polychronis, G. Pagano, VC. Suarez Contreras, T. Yousaf, M. Politis (London, United Kingdom)

    Objective: We aimed to investigate whether speech difficulties are associated with changes in cortical thickness. Background: Speech difficulties are a common debilitating feature of Parkinson’s…
  • 2019 International Congress

    Distributed Global Functional Connectivity Networks Predict Responsiveness to L-DOPA and Subthalamic Deep Brain Stimulation

    C. Wu, T. Foltynie, P. Limousin, L. Zrinzo, H. Akram (Philadelphia, PA, USA)

    Objective: To investigate global resting-state functional connectivity (rsFC) patterns associated with response to L-DOPA and to subthalamic nucleus (STN) deep brain stimulation (DBS) in patients…
  • 2019 International Congress

    Effects of Handwriting Exercise on Functional Outcome in Parkinson’s Disease: A Randomized Controlled Trial

    N. Vorasoot, P. Termsarasab, K. Thadanipon, T. Pulkes (Bangkok, Thailand)

    Objective: To determine whether handwriting exercise could improve writing skill and fine manual function in Parkinson’s disease (PD). Background: PD patients frequently experience micrographia, difficulty…
  • 2019 International Congress

    Clinical Management of Incipient Wearing-off with the 19-Items Wearing off Questionnaire (WOQ-19)

    V. Puente Périz, I. Navalpotro Gómez, A. Crespo Cuevas, A. Puig Pijuan, A. Fernandez Lebrero, D. Lahoz (Barcelona, Spain)

    Objective: To evaluate the use of the 19-items Wearing off Questionnaire (WOQ-19) to detect fluctuations in patients with non-advanced Parkinson's disease (PD) and to evaluate…
  • 2019 International Congress

    The effect of levodopa-carbidopa intestinal gel relative to optimized medical treatment on dyskinesia: Design and baseline characteristics for an open-label, randomized multicenter 12-week study in advanced Parkinson’s disease patients (DYSCOVER Study)

    E. Alvarez, C. Spanaki, E. Pekkonen, L. Manzanares, Y. Liu, O. Sánchez-Soliño, L. Barbato (Elche, Spain)

    Objective: The DYSCOVER study will be the first interventional, randomized study to evaluate the comparative effectiveness of levodopa-carbidopa intestinal gel (LCIG) versus optimized medical treatment…
  • 2019 International Congress

    Effects of zonisamide on parkinsonism in patients with dementia with Lewy bodies by severity of cognitive dysfunction and BPSD: subgroup analysis of pooled data from two trials

    K. Hasegawa, J. Goldman, T. Odawara, K. Kochi, O. Konishi, H. Maruyama, S. Toya, K. Kosaka, M. Murata, I. Mckeith (Kanagawa, Japan)

    Objective: To characterize the efficacy and safety of zonisamide (ZNS) in patients with dementia with Lewy bodies (DLB) with parkinsonism, we performed subgroup analysis by…
  • 2019 International Congress

    Efficacy and Safety of the 5-Hydroxytryptophan on REM Sleep Behavior Disorder in Parkinson’s Disease.

    M. Meloni, M. Figorilli, M. Carta, L. Tamburrino, A. Cannas, M. Fantini, G. Defazio, M. Puligheddu (Cagliari, Italy)

    Objective: To evaluate the efficacy of the 5-HTP on RBD status in patients with Parkinson's disease (PD). Background: REM sleep behavior disorder (RBD) is reported…
  • « Previous Page
  • 1
  • …
  • 122
  • 123
  • 124
  • 125
  • 126
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley